Company Overview of 22nd Century Group, Inc.
22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. It develops smoking cessation products for smokers who are unable or unwilling to quit smoking; and modified risk tobacco products that reduce exposure to certain tobacco smoke toxins compared to conventional cigarettes. The company’s products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy; RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government resear...
9530 Main Street
Clarence, NY 14031
Founded in 1998
Key Executives for 22nd Century Group, Inc.
Total Annual Compensation: $230.2K
President and Director
Total Annual Compensation: $159.6K
Chief Financial Officer
Total Annual Compensation: $83.1K
Vice President of R&D
Total Annual Compensation: $124.2K
Compensation as of Fiscal Year 2013.
22nd Century Group, Inc. Key Developments
22nd Century Group, Inc.(AMEX:XXII) added to Russell 2000 Index
Jul 1 14
22nd Century Group, Inc. will be added to the Russell 2000 Index.
22nd Century Group, Inc.(AMEX:XXII) added to Russell 3000 Index
Jul 1 14
22nd Century Group, Inc. will be added to the Russell 3000 Index.
22nd Century Group, Inc. Appoints Thomas L. James, Esq. as Vice President, General Counsel and Secretary
May 14 14
22nd Century Group, Inc. has appointed Thomas L. James, Esq. as Vice President, General Counsel and Secretary of the company. Mr. James has served over the past 13 years as a Partner and later as an Of Counsel attorney with Foley & Lardner LLP.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries